Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (624) Arrow Down
Filter Results: (624) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (624)
    • People  (2)
    • News  (57)
    • Research  (449)
    • Events  (2)
    • Multimedia  (8)
  • Faculty Publications  (395)

Show Results For

  • All HBS Web  (624)
    • People  (2)
    • News  (57)
    • Research  (449)
    • Events  (2)
    • Multimedia  (8)
  • Faculty Publications  (395)
← Page 21 of 624 Results →
  • March 2024
  • Case

Biomanufacturing Decentralization by Stämm

By: Paul A. Gompers, Jenyfeer Martínez Buitrago and Mariana Cal
In Buenos Aires, Argentina, cousins Llamazares and D’Alvia founded Stämm, a startup based on the idea of decentralizing biomanufacturing processes and downsizing biotech facilities. After raising its seed and series A rounds, and while finalizing its series B round in... View Details
Keywords: Business Model; Business Startups; Entrepreneurship; Venture Capital; Selection and Staffing; Technological Innovation; Science-Based Business; Business Strategy; Commercialization; Growth and Development Strategy; Product Launch; Research and Development; Biotechnology Industry; Latin America; South America; Argentina; Buenos Aires
Citation
Educators
Purchase
Related
Gompers, Paul A., Jenyfeer Martínez Buitrago, and Mariana Cal. "Biomanufacturing Decentralization by Stämm." Harvard Business School Case 824-190, March 2024.
  • October 2023 (Revised May 2024)
  • Case

Thermo Fisher Scientific: Foray into Contract Research

By: Satish Tadikonda, William Marks and Kevin Emancipator
After publicly declaring that they would not enter the contract research organization (CRO) business in 2017, Thermo Fisher purchased Pharmaceutical Product Development (PPD), one of the biggest players in the CRO space, in 2021. Much had changed in the intervening... View Details
Keywords: Mergers and Acquisitions; Customer Focus and Relationships; Corporate Strategy; Organizational Change and Adaptation; Biotechnology Industry
Citation
Educators
Purchase
Related
Tadikonda, Satish, William Marks, and Kevin Emancipator. "Thermo Fisher Scientific: Foray into Contract Research." Harvard Business School Case 824-073, October 2023. (Revised May 2024.)
  • November 2016 (Revised December 2016)
  • Supplement

Anthony Starks at InSiL Therapeutics (B)

By: Vicki Sato and Gary Pisano
This case accompanies the (A) case from Anthony Starks's perspective. View Details
Keywords: Biotech; Management Challenges; R&D; R&D Project Management; Management; Biotechnology Industry; California
Citation
Purchase
Related
Sato, Vicki, and Gary Pisano. "Anthony Starks at InSiL Therapeutics (B)." Harvard Business School Supplement 617-030, November 2016. (Revised December 2016.)
  • October 2011
  • Case

Gene Sequencing: Staking a Position in an Expanding Industry

By: Richard G. Hamermesh, Mara Aspinall and Phillip Andrews
Towards the end of 2010, companies in the gene sequencing industry were pushing aggressive R&D programs to develop technologies and products in the race to sequence the entire human genome at a cost of $1,000. It remained to be seen when the "$1,000 genome" would... View Details
Keywords: Genetics; Business Growth and Maturation; Business Plan; Competition; Venture Capital; Biotechnology Industry
Citation
Find at Harvard
Related
Hamermesh, Richard G., Mara Aspinall, and Phillip Andrews. "Gene Sequencing: Staking a Position in an Expanding Industry." Harvard Business School Case 812-004, October 2011.
  • September 2008 (Revised April 2009)
  • Supplement

Kevin Sharer at Amgen: Sustaining the High-Growth Company (B)

By: William W. George
Kevin Sharer, CEO of Amgen, is assessing the challenges he has faced as a major product came under regulatory scrutiny. View Details
Keywords: Governing Rules, Regulations, and Reforms; Leadership; Product Development; Biotechnology Industry
Citation
Purchase
Related
George, William W. "Kevin Sharer at Amgen: Sustaining the High-Growth Company (B)." Harvard Business School Supplement 409-037, September 2008. (Revised April 2009.)
  • 2009
  • Working Paper

Social Influence Given (Partially) Deliberate Matching: Career Imprints in the Creation of Academic Entrepreneurs

By: Pierre Azoulay, Christopher C. Liu and Toby E. Stuart
Actors often match with associates on a small set of dimensions that matter most for the particular relationship at hand. In so doing, they are exposed to unanticipated social influences because counterparts have more interests, attitudes, and preferences than would-be... View Details
Keywords: Entrepreneurship; Patents; Marketplace Matching; Mathematical Methods; Science-Based Business; Power and Influence; Social and Collaborative Networks; Biotechnology Industry
Citation
Read Now
Related
Azoulay, Pierre, Christopher C. Liu, and Toby E. Stuart. "Social Influence Given (Partially) Deliberate Matching: Career Imprints in the Creation of Academic Entrepreneurs." Harvard Business School Working Paper, No. 09-136, May 2009.
  • September 2003 (Revised March 2007)
  • Case

Direvo Biotech AG

Describes the financing and growth decisions facing Direvo, a young German biotech firm with a customer/partner that wants to become an investor. Also discusses the business model for Direvo's directed evolution technology, with applications in both industrial enzymes... View Details
Keywords: Business Model; Decisions; Business Exit or Shutdown; Value; Business Startups; Biotechnology Industry; Germany
Citation
Educators
Purchase
Related
Roberts, Michael J., Vincent Dessain, and Anders Sjoman. "Direvo Biotech AG." Harvard Business School Case 804-017, September 2003. (Revised March 2007.)
  • April 2002
  • Teaching Note

Anagene, Inc. TN

By: Robert S. Kaplan
Teaching Note for (9-102-030). View Details
Keywords: Entrepreneurship; Public Ownership; Sales; Production; Forecasting and Prediction; Volume; Governing and Advisory Boards; Cost Accounting; Business or Company Management; Financial Reporting; Strategy; Performance Capacity; Biotechnology Industry
Citation
Purchase
Related
Kaplan, Robert S. "Anagene, Inc. TN." Harvard Business School Teaching Note 102-078, April 2002.
  • October 2001 (Revised March 2002)
  • Case

Perlegen Sciences

By: Linda A. Hill and Nicole Tempest
As a biotech start-up company involved in studying human genomes, Perlegen needed to develop an organization that fostered innovation and teamwork among a group of highly trained professionals from both the science and technology fields. Perlegen's CEO, Brad Margus,... View Details
Keywords: Innovation Leadership; Groups and Teams; Management Teams; Problems and Challenges; Business Startups; Genetics; Talent and Talent Management; Innovation Strategy; Biotechnology Industry
Citation
Educators
Purchase
Related
Hill, Linda A., and Nicole Tempest. "Perlegen Sciences." Harvard Business School Case 402-026, October 2001. (Revised March 2002.)
  • August 1985 (Revised May 1986)
  • Case

BioTechnica International

By: Ray A. Goldberg
Keywords: Biotechnology Industry
Citation
Find at Harvard
Related
Goldberg, Ray A. "BioTechnica International." Harvard Business School Case 586-014, August 1985. (Revised May 1986.)
  • November 1995 (Revised March 1996)
  • Case

Ares-Serono (Abridged)

By: Michael Y. Yoshino, Jean-Pierre Jeannet and Carin-Isabel Knoop
Keywords: Biotechnology Industry
Citation
Find at Harvard
Related
Yoshino, Michael Y., Jean-Pierre Jeannet, and Carin-Isabel Knoop. "Ares-Serono (Abridged)." Harvard Business School Case 396-104, November 1995. (Revised March 1996.)
  • 08 Dec 2003
  • Research & Ideas

Why Europe Lags in Pharmaceuticals and Biotech

Governmental, academic, and cultural differences are hurting Europe's chances of creating more competitive pharmaceutical and biotech industries—and not much hope is on the horizon, according to a panel of experts at the 2003 HBS European Business Conference. Although... View Details
Keywords: by Sean Silverthorne; Biotechnology; Biotechnology; Biotechnology; Biotechnology
  • June 1990 (Revised April 1993)
  • Teaching Note

Novo Industri A/S--1981, Teaching Note

By: W. Carl Kester
Teaching Note for (9-286-084). View Details
Keywords: Biotechnology Industry; Biotechnology Industry; Denmark; United States
Citation
Purchase
Related
Kester, W. Carl. "Novo Industri A/S--1981, Teaching Note." Harvard Business School Teaching Note 290-037, June 1990. (Revised April 1993.)
  • April 2024 (Revised November 2024)
  • Case

Moderna: Pioneering a People Platform to Accelerate Science Innovation

By: Tatiana Sandino, Emil Dy and Samuel Grad
Moderna was founded in 2010 to explore how messenger ribonucleic acid (mRNA) could be used to create breakthrough medicines by encoding instructions for the body to create antibodies. When Stéphane Bancel (HBS 2000) took over in 2011, he bet on the potential of this... View Details
Keywords: Disruptive Innovation; Talent and Talent Management; Selection and Staffing; AI and Machine Learning; Digital Strategy; Innovation and Management; Leadership Development; Management Practices and Processes; Management Systems; Organizational Culture; Performance Evaluation; Alignment; Employee Relationship Management; Science-Based Business; Expansion; Biotechnology Industry; Biotechnology Industry; United States
Citation
Educators
Purchase
Related
Sandino, Tatiana, Emil Dy, and Samuel Grad. "Moderna: Pioneering a People Platform to Accelerate Science Innovation." Harvard Business School Case 124-091, April 2024. (Revised November 2024.)
  • November 2020
  • Teaching Note

Valuing Celgene's CVR

By: Benjamin C. Esty and Daniel Fisher
Teaching Note for HBS Case No. 221-031. When Bristol-Myers Squibb (BMS) acquired Celgene Corporation in November 2019, Celgene shareholders received cash, BMS stock, and a contingent value right (CVRs) that would pay $9 if the U.S. Food and Drug Administration (FDA)... View Details
Keywords: Mergers and Acquisitions; Valuation; Value; Judgments; Decision Making; Cash Flow; Financial Instruments; Cognition and Thinking; Biotechnology Industry; Biotechnology Industry; United States
Citation
Purchase
Related
Esty, Benjamin C., and Daniel Fisher. "Valuing Celgene's CVR." Harvard Business School Teaching Note 221-036, November 2020.
  • Spring 2014
  • Article

Attracting Long-Term Investors Through Integrated Thinking and Reporting: A Clinical Study of a Biopharmaceutical Company

By: Andrew Knauer and George Serafeim
Faced with a large percentage of investors that chase short-term returns, companies could benefit by attracting investors with longer-term horizons and incentives that are more consistent with the long-term strategy of the company. The managers of most companies take... View Details
Keywords: Investing; Asset Management; Long-term Investing; Short-termism; Sustainability; Integrated Reporting; Leadership & Corporate Accountability; Pharmaceuticals; Leadership; Integrated Corporate Reporting; Investment; Business and Stakeholder Relations; Corporate Finance; Biotechnology Industry; Biotechnology Industry
Citation
Find at Harvard
Purchase
Related
Knauer, Andrew, and George Serafeim. "Attracting Long-Term Investors Through Integrated Thinking and Reporting: A Clinical Study of a Biopharmaceutical Company." Journal of Applied Corporate Finance 26, no. 2 (Spring 2014): 57–64.
  • 01 May 2009
  • Conference Presentation

The enabling and constraining effects of attention structures on entrepreneurial activity in the U.S. biodiesel industry

By: Shon R. Hiatt
Keywords: Entrepreneurship; Biotechnology Industry; Biotechnology Industry; United States
Citation
Related
Hiatt, Shon R. "The enabling and constraining effects of attention structures on entrepreneurial activity in the U.S. biodiesel industry." Paper presented at the Smith Entrepreneurship Research Conference, May 01, 2009.
  • February 2010
  • Background Note

Millipore Background Note

By: Elie Ofek and Natalie Kindred
This note provides background on Millipore Corporation, a global provider of products and services used primarily in the discovery, development and production of therapeutic drugs. With a track record of quickly adapting to the evolving needs of its customers,... View Details
Keywords: Organizational Change and Adaptation; Customer Focus and Relationships; Biotechnology Industry; Biotechnology Industry
Citation
Find at Harvard
Related
Ofek, Elie, and Natalie Kindred. "Millipore Background Note." Harvard Business School Background Note 510-059, February 2010.
  • July 2009
  • Teaching Note

Khosla Ventures: Biofuels Strategy (TN)

By: Joseph B. Lassiter III
Teaching Note for [809004]. View Details
Keywords: Partners and Partnerships; Growth and Development; Financing and Loans; Investment; Emerging Markets; Renewable Energy; Biotechnology Industry; Biotechnology Industry; Singapore; Kuwait; China
Citation
Purchase
Related
Lassiter, Joseph B., III. "Khosla Ventures: Biofuels Strategy (TN)." Harvard Business School Teaching Note 810-015, July 2009.
  • March 2009
  • Teaching Note

Antegren: A Beacon of Hope (TN)

By: Joshua D. Margolis
Teaching Note for [408025], [408026], [408027], and [408028]. View Details
Keywords: Ethics; Corporate Social Responsibility and Impact; Decision Choices and Conditions; Crisis Management; Biotechnology Industry; Biotechnology Industry
Citation
Purchase
Related
Margolis, Joshua D. "Antegren: A Beacon of Hope (TN)." Harvard Business School Teaching Note 409-096, March 2009.
  • ←
  • 21
  • 22
  • …
  • 31
  • 32
  • →
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.